KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maxlinear (MXL) EBITDA (2016 - 2025)

Maxlinear (MXL) has disclosed EBITDA for 16 consecutive years, with -$14.9 million as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA rose 63.83% to -$14.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$126.9 million, a 43.19% increase, with the full-year FY2025 number at -$126.9 million, up 43.19% from a year prior.
  • EBITDA was -$14.9 million for Q4 2025 at Maxlinear, up from -$41.3 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $51.9 million in Q3 2022 to a low of -$74.6 million in Q1 2024.
  • A 5-year average of -$7.1 million and a median of -$10.4 million in 2023 define the central range for EBITDA.
  • Peak YoY movement for EBITDA: skyrocketed 1669.83% in 2022, then crashed 587.55% in 2024.
  • Maxlinear's EBITDA stood at $29.3 million in 2021, then soared by 40.3% to $41.2 million in 2022, then tumbled by 201.41% to -$41.7 million in 2023, then grew by 1.37% to -$41.2 million in 2024, then soared by 63.83% to -$14.9 million in 2025.
  • Per Business Quant, the three most recent readings for MXL's EBITDA are -$14.9 million (Q4 2025), -$41.3 million (Q3 2025), and -$24.6 million (Q2 2025).